# Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

> **NCT07164859** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Vincent ROULE** · enrollment: 1700 (estimated)

## Conditions studied

- Coronary Artery Disease (CAD)
- Percutaneous Coronary Intervention (PCI)
- Antiplatelet Therapy
- Elderly (People Aged 65 or More)

## Interventions

- **DRUG:** short dual antiplatelet therapy (DAPT) duration
- **DRUG:** Standard DAPT duration

## Key facts

- **NCT ID:** NCT07164859
- **Lead sponsor:** Vincent ROULE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2029-10
- **Final completion:** 2029-10
- **Target enrollment:** 1700 (ESTIMATED)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07164859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07164859, "Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07164859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*